Observational studyToxins2024

Reducing the Impact of Headache and Allodynia Score in Chronic Migraine: An Exploratory Analysis from the Real-World Effectiveness of Anti-CGRP Monoclonal Antibodies Compared to Onabotulinum Toxin A (RAMO) Study.

Danilo Antonio Montisano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.